Caribou Biosciences (CRBU) News Today $1.10 +0.05 (+4.76%) As of 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CRBU Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Jacobs Levy Equity Management Inc. Makes New Investment in Caribou Biosciences, Inc. (NASDAQ:CRBU)Jacobs Levy Equity Management Inc. acquired a new stake in shares of Caribou Biosciences, Inc. (NASDAQ:CRBU - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 1,208,069 shares of the company'May 18 at 4:35 AM | marketbeat.comCantor Fitzgerald Has Negative View of CRBU FY2025 EarningsCaribou Biosciences, Inc. (NASDAQ:CRBU - Free Report) - Stock analysts at Cantor Fitzgerald dropped their FY2025 earnings estimates for shares of Caribou Biosciences in a research note issued on Monday, May 12th. Cantor Fitzgerald analyst R. Bienkowski now anticipates that the company will earn (May 16, 2025 | marketbeat.comDimensional Fund Advisors LP Sells 321,867 Shares of Caribou Biosciences, Inc. (NASDAQ:CRBU)Dimensional Fund Advisors LP decreased its position in shares of Caribou Biosciences, Inc. (NASDAQ:CRBU - Free Report) by 15.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,732,378 shares of the compaMay 16, 2025 | marketbeat.comCaribou Biosciences, Inc. (NASDAQ:CRBU) Given Average Rating of "Buy" by BrokeragesCaribou Biosciences, Inc. (NASDAQ:CRBU - Get Free Report) has been assigned an average rating of "Buy" from the five brokerages that are covering the company, MarketBeat Ratings reports. Five equities research analysts have rated the stock with a buy recommendation. The average 12-month target priMay 13, 2025 | marketbeat.comCaribou Biosciences (NASDAQ:CRBU) and Invizyne Technologies (NASDAQ:IZTC) Head-To-Head ContrastMay 10, 2025 | americanbankingnews.comCaribou Biosciences Reports First Quarter 2025 Financial Results and Provides Business UpdateMay 9, 2025 | finance.yahoo.comCaribou Biosciences Reports First Quarter 2025 Financial Results and Provides Business UpdateMay 8, 2025 | globenewswire.comCaribou Biosciences to Participate in the BofA Securities 2025 Health Care ConferenceMay 6, 2025 | globenewswire.comSchonfeld Strategic Advisors LLC Purchases 467,738 Shares of Caribou Biosciences, Inc. (NASDAQ:CRBU)Schonfeld Strategic Advisors LLC lifted its position in shares of Caribou Biosciences, Inc. (NASDAQ:CRBU - Free Report) by 28.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 2,113,272 shares of the company'May 6, 2025 | marketbeat.comHC Wainwright Has Optimistic Outlook of CRBU Q2 EarningsCaribou Biosciences, Inc. (NASDAQ:CRBU - Free Report) - Equities research analysts at HC Wainwright lifted their Q2 2025 earnings per share (EPS) estimates for Caribou Biosciences in a note issued to investors on Monday, April 28th. HC Wainwright analyst R. Burns now forecasts that the company wiMay 3, 2025 | marketbeat.comCaribou Biosciences (CRBU) to Release Earnings on TuesdayCaribou Biosciences (NASDAQ:CRBU) will be releasing its Q1 2025 earnings before the market opens on Tuesday, May 6. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-6-caribou-biosciences-inc-stock/)May 1, 2025 | marketbeat.comCaribou Biosciences, Inc. Announces Strategic Pipeline Prioritization and Workforce Reductions to Extend Cash Runway into H2 2027April 26, 2025 | nasdaq.comCaribou reduces workforce by 32%, discontinues GALLOP and AMpLify trialsApril 25, 2025 | markets.businessinsider.comCaribou Biosciences, Inc.: Caribou Biosciences Announces Strategic Pipeline Prioritization with Focus on CB-010 and CB-011 Oncology ProgramsApril 25, 2025 | finanznachrichten.deCaribou cuts pipeline and workforce to focus on lead CAR-T programmesApril 25, 2025 | finance.yahoo.comCaribou to prioritize lead cancer programs in portfolio shakeupApril 25, 2025 | msn.comCaribou Biosciences Announces Strategic Pipeline Prioritization with Focus on CB-010 and CB-011 Oncology ProgramsApril 24, 2025 | globenewswire.comCaribou Biosciences, Inc. (NASDAQ:CRBU) Shares Bought by JPMorgan Chase & Co.JPMorgan Chase & Co. lifted its holdings in shares of Caribou Biosciences, Inc. (NASDAQ:CRBU - Free Report) by 475.9% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 2,495,922 shares of the company's stock after purchasinApril 22, 2025 | marketbeat.comEquities Analysts Set Expectations for CRBU Q1 EarningsCaribou Biosciences, Inc. (NASDAQ:CRBU - Free Report) - Equities research analysts at Leerink Partnrs issued their Q1 2025 earnings per share (EPS) estimates for Caribou Biosciences in a report issued on Wednesday, April 16th. Leerink Partnrs analyst M. Foroohar forecasts that the company will poApril 20, 2025 | marketbeat.comLeerink Partnrs Has Negative Outlook of CRBU FY2029 EarningsCaribou Biosciences, Inc. (NASDAQ:CRBU - Free Report) - Analysts at Leerink Partnrs decreased their FY2029 earnings per share (EPS) estimates for shares of Caribou Biosciences in a research report issued on Wednesday, April 16th. Leerink Partnrs analyst M. Foroohar now forecasts that the companyApril 19, 2025 | marketbeat.comCaribou Biosciences, Inc. (NASDAQ:CRBU) Receives Consensus Rating of "Buy" from AnalystsCaribou Biosciences, Inc. (NASDAQ:CRBU - Get Free Report) has been assigned an average rating of "Buy" from the five brokerages that are currently covering the stock, Marketbeat Ratings reports. Five analysts have rated the stock with a buy rating. The average 1 year target price among analysts thApril 19, 2025 | marketbeat.comCaribou Biosciences, Inc. (NASDAQ:CRBU) Short Interest Down 13.7% in MarchCaribou Biosciences, Inc. (NASDAQ:CRBU - Get Free Report) saw a large drop in short interest in the month of March. As of March 15th, there was short interest totalling 8,820,000 shares, a drop of 13.7% from the February 28th total of 10,220,000 shares. Currently, 10.9% of the shares of the stock are sold short. Based on an average daily volume of 1,290,000 shares, the days-to-cover ratio is currently 6.8 days.April 4, 2025 | marketbeat.comWhat is HC Wainwright's Forecast for CRBU Q1 Earnings?Caribou Biosciences, Inc. (NASDAQ:CRBU - Free Report) - Research analysts at HC Wainwright issued their Q1 2025 earnings per share estimates for shares of Caribou Biosciences in a research note issued on Wednesday, March 19th. HC Wainwright analyst R. Burns forecasts that the company will earn ($March 22, 2025 | marketbeat.comCaribou Biosciences (NASDAQ:CRBU) Given Buy Rating at HC WainwrightHC Wainwright reissued a "buy" rating and issued a $9.00 price target on shares of Caribou Biosciences in a research note on Wednesday.March 20, 2025 | marketbeat.comCaribou Biosciences, Inc. (NASDAQ:CRBU) CEO Rachel E. Haurwitz Acquires 20,000 SharesCaribou Biosciences, Inc. (NASDAQ:CRBU - Get Free Report) CEO Rachel E. Haurwitz acquired 20,000 shares of the stock in a transaction that occurred on Friday, March 14th. The stock was acquired at an average cost of $1.02 per share, with a total value of $20,400.00. Following the completion of the purchase, the chief executive officer now owns 3,369,395 shares of the company's stock, valued at $3,436,782.90. This trade represents a 0.60 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.March 18, 2025 | marketbeat.comEvercore ISI Sticks to Their Hold Rating for Caribou Biosciences (CRBU)March 14, 2025 | markets.businessinsider.comBrookline Capital Management Weighs in on CRBU Q1 EarningsCaribou Biosciences, Inc. (NASDAQ:CRBU - Free Report) - Research analysts at Brookline Capital Management issued their Q1 2025 earnings per share (EPS) estimates for Caribou Biosciences in a research report issued on Tuesday, March 11th. Brookline Capital Management analyst L. Cann expects that tMarch 14, 2025 | marketbeat.comFY2029 EPS Estimates for CRBU Decreased by AnalystCaribou Biosciences, Inc. (NASDAQ:CRBU - Free Report) - Equities research analysts at Brookline Capital Management decreased their FY2029 earnings per share estimates for Caribou Biosciences in a research report issued to clients and investors on Tuesday, March 11th. Brookline Capital ManagementMarch 13, 2025 | marketbeat.comCaribou Biosciences, Inc.: Caribou Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business UpdateMarch 12, 2025 | finanznachrichten.deCaribou Biosciences Advances CRISPR Therapies Amid Financial ChallengesMarch 12, 2025 | tipranks.comCaribou Biosciences (NASDAQ:CRBU) Announces Earnings Results, Beats Expectations By $0.01 EPSCaribou Biosciences (NASDAQ:CRBU - Get Free Report) issued its quarterly earnings results on Monday. The company reported ($0.39) earnings per share for the quarter, topping analysts' consensus estimates of ($0.40) by $0.01. Caribou Biosciences had a negative return on equity of 45.46% and a negative net margin of 1,290.81%.March 11, 2025 | marketbeat.comCaribou Biosciences reports Q4 EPS (39c), consensus (42c)March 10, 2025 | markets.businessinsider.comCaribou Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business UpdateMarch 10, 2025 | globenewswire.comCARIBOU ALERT: Bragar Eagel & Squire, P.C. is Investigating Caribou Biosciences, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmMarch 6, 2025 | globenewswire.comCaribou Biosciences (CRBU) Expected to Announce Quarterly Earnings on MondayCaribou Biosciences (NASDAQ:CRBU) will be releasing earnings before the market opens on Monday, March 10, Financial Modeling Prep reports.March 3, 2025 | marketbeat.comCaribou Biosciences, Inc. (NASDAQ:CRBU) Receives Consensus Recommendation of "Buy" from AnalystsCaribou Biosciences, Inc. (NASDAQ:CRBU - Get Free Report) has received an average recommendation of "Buy" from the five research firms that are presently covering the stock, MarketBeat Ratings reports. Five analysts have rated the stock with a buy recommendation. The average twelve-month price objFebruary 26, 2025 | marketbeat.comCaribou Biosciences, Inc. (NASDAQ:CRBU) is a favorite amongst institutional investors who own 62%February 25, 2025 | finance.yahoo.comCRBU Deadline: CRBU Investors Have Opportunity to Lead Caribou Biosciences, Inc. Securities Fraud LawsuitFebruary 24, 2025 | prnewswire.comCaribou Biosciences, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses; February 24, 2025 Deadline to file Lead Plaintiff MotionFebruary 24, 2025 | globenewswire.comLevi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Caribou Biosciences, Inc. (CRBU) ShareholdersFebruary 24, 2025 | globenewswire.comShareholders of Caribou Biosciences, Inc. ...February 24, 2025 | gurufocus.comShareholders of Caribou Biosciences, Inc. Should Contact The Gross Law Firm Before February 24, 2025 to Discuss Your Rights - CRBUFebruary 24, 2025 | prnewswire.comFINAL CRBU DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Caribou Biosciences, Inc. Investors to Join the Class Action LawsuitFebruary 23, 2025 | investing.comCRBU DEADLINE ALERT: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Caribou Biosciences, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important February 24 Deadline inFebruary 23, 2025 | investing.comCRBU DEADLINE NOTICE: ROSEN, NATIONAL TRIAL COUNSEL, Encourages Caribou Biosciences, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important February 24 Deadline in Securities Class Action – CRBUFebruary 22, 2025 | globenewswire.comFebruary 24, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against CRBUFebruary 21, 2025 | prnewswire.comThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of February 24, 2025 in Caribou Biosciences, Inc. Lawsuit – CRBUFebruary 20, 2025 | globenewswire.comFaruqi & Faruqi Reminds Caribou Biosciences Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 24, 2025 - CRBUFebruary 20, 2025 | prnewswire.comCaribou Biosciences, Inc. Class Action: The Gross Law Firm Reminds Caribou Biosciences, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 24, 2025 - CRBUFebruary 20, 2025 | prnewswire.comCRBU Deadline: CRBU Investors Have Opportunity to Lead Caribou Biosciences, Inc. Securities Fraud LawsuitFebruary 19, 2025 | prnewswire.com Get Caribou Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for CRBU and its competitors with MarketBeat's FREE daily newsletter. Email Address CRBU Media Mentions By Week CRBU Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CRBU News Sentiment▼0.360.65▲Average Medical News Sentiment CRBU News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CRBU Articles This Week▼64▲CRBU Articles Average Week Get Caribou Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for CRBU and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Atyr PHARMA News Today Atai Life Sciences News Today Aurora Cannabis News Today Aquestive Therapeutics News Today Compass Therapeutics News Today DBV Technologies News Today Corvus Pharmaceuticals News Today Immutep News Today Cartesian Therapeutics News Today Aura Biosciences News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CRBU) was last updated on 5/20/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredMemorial Day: 59% dividend from Bitcoin (No Crypto Needed)140% Dividends from stocks like Tesla? Discover How for Just $9! For Memorial Day, get the full details of ...Investors Alley | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredExclusive Offer: Target 100% Returns NowBrace yourself–this may come as a shock. It turns out that you may not have to wait decades to turn a small...ProsperityPub | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Caribou Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Caribou Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CRBU Stock Free CRBU Stock Alerts